The Cooper Cos., Inc. (COO)
57.40
+2.52
(+4.59%)
USD |
NASDAQ |
Oct 15, 16:00
57.20
-0.20
(-0.35%)
After-Hours: 05:52
Cooper Cos. Research and Development Expense (Quarterly) : 41.60M for July 31, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 41.60M |
| April 30, 2026 | 42.50M |
| January 31, 2026 | 44.30M |
| October 31, 2025 | 41.40M |
| July 31, 2025 | 44.60M |
| April 30, 2025 | 45.50M |
| January 31, 2025 | 40.70M |
| October 31, 2024 | 37.70M |
| July 31, 2024 | 39.00M |
| April 30, 2024 | 38.90M |
| January 31, 2024 | 39.50M |
| October 31, 2023 | 36.70M |
| July 31, 2023 | 36.50M |
| April 30, 2023 | 32.60M |
| January 31, 2023 | 31.60M |
| October 31, 2022 | 29.10M |
| July 31, 2022 | 28.70M |
| April 30, 2022 | 26.30M |
| January 31, 2022 | 26.20M |
| October 31, 2021 | 25.60M |
| July 31, 2021 | 24.80M |
| April 30, 2021 | 21.00M |
| January 31, 2021 | 21.40M |
| October 31, 2020 | 25.50M |
| July 31, 2020 | 21.80M |
| Date | Value |
|---|---|
| April 30, 2020 | 23.80M |
| January 31, 2020 | 22.20M |
| October 31, 2019 | 23.30M |
| July 31, 2019 | 21.50M |
| April 30, 2019 | 21.00M |
| January 31, 2019 | 21.00M |
| October 31, 2018 | 22.50M |
| July 31, 2018 | 22.50M |
| April 30, 2018 | 20.80M |
| January 31, 2018 | 18.80M |
| October 31, 2017 | 18.50M |
| July 31, 2017 | 17.50M |
| April 30, 2017 | 16.80M |
| January 31, 2017 | 16.30M |
| October 31, 2016 | 17.94M |
| July 31, 2016 | 15.90M |
| April 30, 2016 | 16.70M |
| January 31, 2016 | 14.66M |
| October 31, 2015 | 18.36M |
| July 31, 2015 | 18.10M |
| April 30, 2015 | 16.62M |
| January 31, 2015 | 16.01M |
| October 31, 2014 | 18.18M |
| July 31, 2014 | 16.07M |
| April 30, 2014 | 16.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 36.32M |
| Stryker Corp. | 424.00M |
| Boston Scientific Corp. | 554.00M |
| West Pharmaceutical Services, Inc. | 19.70M |
| Abbott Laboratories | 892.00M |